Johns Hopkins at the ACR Annual Meeting

Johns Hopkins professors will participate in ACR Convergence 2025 from October 24–29. Choose a date below to see the schedule of presentations and additional details. All times listed are in Central Standard Time (CST).

View schedule by date:
Oct. 24 | Oct. 25 | Oct. 26 | Oct. 27 | Oct. 28 | Oct. 29

Friday October 24, 2025

Faculty Name	Presentation Time	Presentation Type	Title	Location
Phil Seo	4:10PM-5:30PM	Roundtables	FIT Program: Learning from the Expert: Rheumatology Roundtables: Tapering Biologics in Vasculitis	W375A

Saturday October 25, 2025

Faculty name	Time	Presentation Type	Title	Location
Maximilian F. Konig	10:45AM-11:15AM	Session II (a)	Session II (a): CAR-T and Beyond: Cellular Therapies in Autoimmune Disease: Clinical Repurposing of Current TCEs Approved for B Cell Cancers for Autoimmune Diseases as Compared to Designing Them from Scratch for Autoimmune Disease Indications	W375B

Sunday October 26, 2025

Faculty name	Time	Presentation Type	Title	Location
Julie Paik	9:00AM-10:30AM	Scientific Session	26S12: Management of Challenging Cases in Myositis	W183A-C
Michelle Petri	9:45AM-10:00AM	Plenary Session	0772: Redefining When to Biopsy the Kidney in Patients with SLE	W375D-E
Dan Goldman	10:30AM-12:30PM	Poster Session A	0607: Age at Diagnosis of SLE has Increased in a United States Longitudinal Cohort	Poster Hall
Andrew Mammen	10:30AM-12:30PM	Poster Session A	0296: Aggregation of HARS1 and internalized antibodies in muscle biopsies of patients with antisynthetase syndrome and anti-Jo1(HARS) autoantibodies	Poster Hall
Christopher A. Mecoli	10:30AM-12:30PM	Poster Session A	0288: Predictors and Characteristics of Objective Flares in Adult Dermatomyositis	Poster Hall
Ana-Maria Orbai	10:30AM-12:30PM	Poster Session A	0529: Anti-PeptidylArginine Deiminase-2 (anti-PAD2) Autoantibodies in Psoriatic Arthritis	Poster Hall
Michelle Petri	10:30AM-12:30PM	Poster Session A	0597: Low 25-hydroxyvitamin D Levels are Associated with Higher Mortality and More Cardiovascular Events in Systemic Lupus Erythematosus	Poster Hall
Michelle Petri	10:30AM-12:30PM	Poster Session A	0607: Age at Diagnosis of SLE has Increased in a United States Longitudinal Cohort	Poster Hall
Ross Gilbert	10:30AM-12:30PM	Poster Session A	0218: Retrieving data. Wait a few seconds and try to cut or copy again.	Poster Hall
Maximilian F. Konig	1:30PM-2:00PM	Scientific Session	The New Rules of the Road: An Update on CAR-T-Mediated Immune Reset for SLE: Precision Immunotherapy - T-cell Engineering	W375D-E
Michelle Petri	3:00PM-3:15PM	Abstract Session	0837: Risk of New Proteinuria in Next Ten Years in SLE	S102
Alan Baer	2:30PM-3:00PM	Scientific Session	The Bedside Educator: Best Practices for Bedside Instruction in Rheumatology: Mastering the Art of Bedside Teaching in Rheumatology	W185A-D
Andrea Fava	3:45PM-4:00PM	Abstract Session	0840: Shared and Distinct Urinary Proteomic Signatures of Lupus Nephritis and Other Glomerular Diseases	S102
Andrea Fava	4:15PM-4:30PM	Abstract Session	0851: Association of urinary biomarkers with histological features in diagnostic and per-protocol repeat kidney biopsies in lupus nephritis	S102
Laura Hummers	4:00PM-5:00PM	Meet the Professor	Systemic Sclerosis	W175B
Michelle Petri	5:30PM-7:30PM	Industry-Supported Symposium	ITS6: Expert Perspectives on Targeting DORIS Remission and Emerging Clinical Data for a Novel Treatment	Regency Ballroom AB, Hyatt Regency

Monday October 27, 2025

Faculty name	Time	Presentation Type	Title	Location
Laura Hummers	7:30AM-8:30AM	Meet the Professor	Systemic Sclerosis	W175B
Brit Adler	8:00AM-9:30AM	Scientific Session	27M02: Nutrition for Rheumatic Disease: Where Aging Biology, Sarcopenia, and Diet Intersect	W375A
Andrea Fava	8:30AM-8:45AM	Plenary Session	0851: Urinary Tenascin C Predicts Kidney Function Loss in Lupus Nephritis	W375D-E
Andrew Mammen	8:30AM-9:00AM	Scientific Session	Strengthening Our Understanding of Less Common Forms of Inflammatory Myopathies: Immune-Mediated Necrotizing Myopathies and Beyond	S102
Andrew Mammen	10:30AM-10:45AM	Abstract Session	0963: Myeloid Dendritic Cell Subsets Characterize Muscle of Inclusion Body Myositis Patients and Correlate with KLRG1+ and TBX21+ CD8+ T cells	S102
Jemima Albayda	10:30AM-12:30PM	Poster Session B	1204: Validity and reliability of a new ultrasound-based semiquantitative echogenicity grading scale for myositis.	Poster Hall
Laura Cappelli	10:30AM-12:30PM	Poster Session B	1108: Baseline Features, Immunosuppression, and Immune-Related Adverse Events in Patients with Pre-existing Rheumatic Disease and Cancer Requiring Immune Checkpoint Inhibitor Therapy	Poster Hall
Laura Cappelli	10:30AM-12:30PM	Poster Session B	1117: Inflammatory Arthritis after Hematopoietic Stem Cell Transplant: A Case Series and Literature Review	Poster Hall
Laura Cappelli	10:30AM-12:30PM	Poster Session B	1107: Baseline Data on Rheumatic Immune-related Adverse Events from the Largest Prospective Multicenter US Consortium	Poster Hall
Andrea Fava	10:30AM-12:30PM	Poster Session B	1480: Urinary Biomarkers Detect Proliferative Lupus Nephritis in SLE Patients with Subclinical Proteinuria.	Poster Hall
Peter (Zixing) Liu	10:30AM-12:30PM	Poster Session B	1028: Enhanced Assessment of Psoriatic Arthritis Disease Progression Using cDAPSA plus the Contrast of Patient Reported Pain and Global Assessment versus Joint Counts	Poster Hall
Ning Meng	10:30AM-12:30PM	Poster Session B	1037: Risk Factor Identification and Dynamic Individualized Prediction of Muscle Involvement in Systemic Sclerosis	Poster Hall
Christopher A. Mecoli	10:30AM-12:30PM	Poster Session B	1207: Cutaneous and Muscular Disease Trajectories in Adult Patients with Dermatomyositis	Poster Hall
Michelle Petri	10:30AM-12:30PM	Poster Session B	1499: Predictors of Proteinuria Flares in Biopsy Positive Lupus Nephritis	Poster Hall
Michelle Petri	10:30AM-12:30PM	Poster Session B	1251: Steroids and Me (Sam): engaging and educating steroid-treated patients via patient advocacy partnerships and internet search channels.	Poster Hall
Michelle Petri	10:30AM-12:30PM	Poster Session B	1498: Both Race and Socioeconomic Status Affect Mortality in SLE	Poster Hall
Michelle Petri	10:30AM-12:30PM	Poster Session B	1516: The Benefits of SGLT2i on GFR Slope and Proteinuria in SLE Depend on Subgroups of Diabetes Mellitus and Baseline eGFR	Poster Hall
Ami Shah	10:30AM-12:30PM	Poster Session B	1107: Baseline Data on Rheumatic Immune-related Adverse Events from the Largest Prospective Multicenter US Consortium	Poster Hall
Brendan Denvir	10:30AM-12:30PM	Poster Session B	1596: GPA-Associated Tracheobronchial Stenosis: Immunosuppressant Use and Dilation Frequency	Poster Hall
Brendan Denvir	10:30AM-12:30PM	Poster Session B	1595: Subcordal Stenosis is a Glucocorticoid-Responsive Manifestation of Granulomatosis with Polyangiitis	Poster Hall
Christopher A. Mecoli	11:00AM-11:15AM	Abstract Session	0865: Spatial Transcriptomic Analysis of Calcinosis Cutis in Dermatomyositis Uncovers Disease-Associated Pathways Involving IL-6, Tissue Remodeling, and Osteopontin	W190A-B
Brit Adler	1:00PM-1:30PM	Scientific Session	POTS: Postural Tachycardia Syndrome or Is It?: Overview of Differential Diagnosis of POTS and Its Link to Other Other Etiologies	W184A
Andrea Fava	1:00PM-1:30PM	Scientific Session	Bench to Bedside in the Diagnosis and Treatment of Lupus Nephritis: Applying Learnings from the AMP Program into the Clinic	W196A-C
Brit Adler	4:00PM-5:00PM	Scientific Session	27M72: Cancer Immunotherapy and Its Toxicities, Today and Tomorrow	W375A
Julie Paik	5:30PM-7:30PM	Industry-Supported Symposium	ITS9: Therapeutic Frontiers in Rheumatology: Investigating the Effects of FcRn Blockade on Autoimmunity	Grand Horizon Ballroom C, Marriott Marquis

Tuesday October 28, 2025

Faculty name	Time	Presentation Type	Title	Location
Alan Baer	7:30AM-8:30AM	Meet the Professor	Sjögren's Disease	W175C
Andrea Fava	10:30AM-12:30PM	Poster Session C	2436: Preload deficiency as a treatable cause of fatigue and exercise intolerance in SLE	Poster Hall
Thomas Grader-Beck	10:30AM-12:30PM	Poster Session C	2302: Clustering by ESSPRI and PROMIS domain measures defines distinct subtypes and facilitates longitudinal assessment of patients with Sjogren’s disease	Poster Hall
Ana-Maria Orbai	10:30AM-12:30PM	Poster Session C	2341: Bimekizumab Treatment Resulted in Long-Term Sustained Reductions in Disease Impact Assessed by the Psoriatic Arthritis Impact of Disease (PsAID)-12 Questionnaire in Patients with Active Psoriatic Arthritis: Up to 3-Year Results from Two Phase 3 Studies	Poster Hall
Julie Paik	10:30AM-12:30PM	Poster Session C	2063: Linking PROMIS scores to disease severity and treatment in dermatomyositis: a patient-centered evaluation	Poster Hall
Julie Paik	1:40PM-2:00PM	Scientific Session	Getting to the Heart of the Issue: Perimyocarditis in Autoimmune Diseases: Case Presentations on Lupus and Myositis	W375A
Alan Baer	4:00PM-5:00PM	Meet the Professor	Sjögren's Disease	W175C
Christopher A. Mecoli	5:30PM-7:30PM	Industry-Supported Symposium	ITS7: Understanding Collaborative Care in Autoimmune-Associated Interstitial Lung Disease (ILD)	Grand Horizon Ballroom EF, Marriott Marquis
Phil Seo	5:30PM-7:30PM	Industry-Supported Symposium	ITS16: From Delay to Damage: Changing the EGPA Trajectory with Early Diagnosis and Biologic Therapy	Regency Ballroom CDE, Hyatt Regency
Thomas Grader-Beck	5:30PM-7:30PM	Industry-Supported Symposium	ITS2: The Evolving Understanding of Sjögren’s Disease: Patient Experiences, Pathophysiological Insights, and Novel Treatments on the Horizon	Grand Horizon Ballroom AB, Marriott Marquis

Wednesday October 29, 2025

Faculty name	Time	Presentation Type	Title	Location
Thomas Grader-Beck	9:15 AM - 9:30 AM	Abstract Session	LB24: Ianalumab demonstrates significant reduction in disease activity in patients with Sjögren's disease: Efficacy and safety results from two global Phase 3, randomized, placebo-controlled double-blind studies (NEPTUNUS-1 and NEPTUNUS-2)	W375C
Thomas Grader-Beck	12:00PM-12:15PM	Abstract Session	2665: Preexisting Antibodies Against Vaccine Antigens Are Preserved In Patients With Systemic Lupus Erythematosus and Sjögren’s Disease Upon Ianalumab Treatment While Autoantibodies Decline	W190A-B